Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026)
Fortrea Holdings (FTRE) posted Change in Account Payables of $41.3 million for Q1 2026, up 304.46% on a QoQ basis from -$20.2 million in Q4 2025, and up 245.42% year-over-year from $12.0 million in Q1 2025.
Fortrea Holdings (FTRE) Change in Account Payables (2022 - 2026) Analysis & Trends
Fortrea Holdings' Change in Account Payables history runs 5 years deep, the most recent figure standing at $41.3 million for Q1 2026.
- Quarterly Change in Account Payables rose 245.42% year-over-year to $41.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.2 million (down 98.03% YoY) and the FY2025 annual result came in at -$109.9 million, down 1626.39% from the prior year.
- Change in Account Payables was $41.3 million for Q1 2026 at Fortrea Holdings, up from -$20.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $41.3 million in Q1 2026 and bottomed at -$42.9 million in Q3 2025.
- A 5-year average of -$120000.0 and a median of $1.3 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2024 — Change in Account Payables soared 2880.0% — and 2025, when it plunged 3055.56%.
- Fortrea Holdings' Change in Account Payables stood at $1.3 million in 2022, then surged by 623.08% to $9.4 million in 2023, then plunged by 85.11% to $1.4 million in 2024, then slumped by 1542.86% to -$20.2 million in 2025, then surged by 304.46% to $41.3 million in 2026.
- Business Quant data shows FTRE's Change in Account Payables at $41.3 million in Q1 2026, -$20.2 million in Q4 2025, and -$42.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 41.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.30 Mn |
| Mar 31, 2026 | 41.30 Mn |
| Dec 31, 2025 | -20.20 Mn |
| Dec 31, 2025 | -20.20 Mn |
| Sep 30, 2025 | -42.90 Mn |
| Sep 30, 2025 | -42.90 Mn |
| Jun 30, 2025 | -18.40 Mn |
| Jun 30, 2025 | -18.40 Mn |
| Mar 31, 2025 | -28.40 Mn |
| Mar 31, 2025 | -28.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | -900,000.00 |
| Mar 31, 2024 | -900,000.00 |
| Dec 31, 2023 | 9.40 Mn |
| Dec 31, 2023 | 9.40 Mn |